volume 110, issue 2, P610-614 2021
DOI: 10.1016/j.xphs.2020.10.047
View full text
|
Sign up to set email alerts
|
Share

Abstract: The Formulation Workstream of the BioPhorum Development Group (BPDG), an industry-wide consortium, has identified the increased use of closed system drug-transfer devices (CSTDs) with biologics, without an associated compatibility assessment, to be of significant concern. The use of CSTDs has increased significantly in recent years due to the recommendations by NIOSH and USP that they be used during preparation and administration of hazardous drugs. While CSTDs are valuable in the healthcare setting to reduce …

Expand abstract